Variations in the activity of a protein called p21 may underlie the differences in the activity of myelin-repairing cells in the brains of people with multiple sclerosis (MS), according to a new study. The findings may help to explain why different people with MS develop different forms of…
Exercises to strengthen the respiratory muscles — the muscles in the chest needed to move air in and out of the lungs when breathing — can help improve lung function in people with multiple sclerosis (MS), according to a new analysis. This type of exercise, known as respiratory muscle…
Discussion
Not long ago, while the family was all together in the car, a squirrel ran into the road in front of us. It froze for a couple seconds, then darted one way, and then another, before finally choosing a direction. Fortunately, it turned out to be the right direction. Watching…
IMP761, an experimental immunosuppressive therapy being developed by Immutep for multiple sclerosis (MS) and other autoimmune diseases, was well tolerated in healthy volunteers when given at single increasing doses. The findings come from the single-ascending dose portion of an ongoing Phase 1 clinical trial (NCT06637865), which tested…
An experimental therapy designed to eliminate harmful B-cells — key drivers of inflammation in multiple sclerosis (MS) and other autoimmune diseases — has reached an early development milestone. The treatment candidate, CDR111, is being developed under a collaboration between CDR-Life and Boehringer Ingelheim. The milestone was achieved…
Get regular updates to your inbox.
